Ecromeximab
Modify Date: 2024-08-13 17:54:14
Ecromeximab structure
|
Common Name | Ecromeximab | ||
|---|---|---|---|---|
| CAS Number | 292819-64-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EcromeximabEcromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells[1]. |
| Name | Kw-2871 |
|---|
| Description | Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Ecromeximab. IMGT. |
| No Any Chemical & Physical Properties |